Kinross Gold Corporation:企業のM&A・事業提携・投資動向

◆英語タイトル:Kinross Gold Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1745
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:135
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:金属・鉱業
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Kinross Gold Corporation – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Kinross Gold Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Kinross Gold Corporation since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Kinross Gold Corporation’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Kinross Gold Corporation. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Kinross Gold Corporation’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Kinross Gold Corporation and its subsidiaries since 2007.
- Information about key financial and legal advisors for Kinross Gold Corporation’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Kinross Gold Corporation’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 9
Mergers and Acquisitions – Overview 9
Mergers and Acquisitions – Deal reports 10
CORPORATE VENTURING 42
Corporate Venturing – Overview 42
Corporate Venturing – Deal reports 43
PARTNERSHIP 68
Partnership – Deal reports 68
CAPITAL RAISING 70
Capital Raising – Overview 70
Capital Raising – Deal reports 71
DIVESTMENTS 77
Divestments – Overview 77
Divestments – Deal reports 78
PRIVATE EQUITY & OWNERSHIP 122
Private Equity and Ownership – Deal reports 122
APPENDIX 125
Contact Us 125
About MarketLine Financial Deals Database 125
Deal Definition and Methodology 127
About MarketLine 134

List of Tables
Table 1: Kinross Gold Corporation M&A volume and value trend (2014-YTD2018)
Table 2: Kinross Gold Corporation M&A activity by geography (2014-YTD2018)
Table 3: Kinross Gold Corporation corporate venturing volume and value trend (2014-YTD2018)
Table 4: Kinross Gold Corporation corporate venturing by geography (2014-YTD2018)
Table 5: Kinross Gold Corporation capital raising volume and value trend (2014-YTD2018)
Table 6: Kinross Gold Corporation capital raising by deal type (2014-YTD2018)
Table 7: Kinross Gold Corporation divestments volume and value trend (2014-YTD2018)
Table 8: Kinross Gold Corporation divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Kinross Gold Corporation M&A volume and value trend (2014-YTD2018)
Figure 2: Kinross Gold Corporation M&A activity by geography (2014-YTD2018)
Figure 3: Kinross Gold Corporation corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Kinross Gold Corporation corporate venturing by geography (2014-YTD2018)
Figure 5: Kinross Gold Corporation capital raising volume and value trend (2014-YTD2018)
Figure 6: Kinross Gold Corporation capital raising by deal type (2014-YTD2018)
Figure 7: Kinross Gold Corporation divestments volume and value trend (2014-YTD2018)
Figure 8: Kinross Gold Corporation divestments by geography (2014-YTD2018)

★海外企業調査レポート[Kinross Gold Corporation:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Terumo BCT Inc:企業の戦略的SWOT分析
    Terumo BCT Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Suzano Papel e Celulose SA (SUZB5):企業の財務・戦略的SWOT分析
    Suzano Papel e Celulose SA (SUZB5) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • The York Water Co (YORW):企業の財務・戦略的SWOT分析
    The York Water Co (YORW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Micell Technologies Inc:製品パイプライン分析
    Summary Micell Technologies Inc (Micell) is a medical device company that develops drug delivery systems for the treatment of cardiovascular diseases. The company offers product such as MiStent sirolimus eluting absorbable polymer coronary stent system, a drug-eluting stent that is designed to optim …
  • Nuvo Pharmaceuticals Inc (NRI):製薬・医療:M&Aディール及び事業提携情報
    Summary Nuvo Pharmaceuticals Inc (Nuvo), formerly Nuvo Research Inc, is a healthcare company that offers portfolio of commercial products and pharmaceutical manufacturing capabilities. The company’s product portfolio includes pennsaid, heated lidocaine and tetracaine patches. Its products deliver dr …
  • Mayne Pharma Group Ltd (MYX):製薬・医療:M&Aディール及び事業提携情報
    Summary Mayne Pharma Group Ltd (Mayne Pharma), formerly HalcyGen Pharmaceuticals Ltd, a subsidiary of Mayne Pharma Group Ltd, is a specialty pharmaceutical company that manufactures and markets branded and generic medicinal products. The company’s products comprise erymax capsules, kapanol capsules, …
  • Sino-Ocean Land Holdings Limited:戦略・SWOT・企業財務分析
    Sino-Ocean Land Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Sino-Ocean Land Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Motif BioSciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Motif BioSciences Inc (Motif), a subsidiary of Motif Bio Plc is a clinical stage biopharmaceutical company that manufactures novel antibiotics designed to treat life-threatening infections caused by multi-drug resistant bacteria. The company’s product programs include MTF-001, iclaprim, and …
  • Synthetic Genomics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Synthetic Genomics Inc (Synthetic Genomics) is a provider of synthetic biology and synthetic genomics solutions. The company provides DNA synthesis services, instrumentation, reagents, and bioinformatics services and software packages, among others. It provides solutions in genomics research …
  • CEL-SCI Corp (CVM)-製薬・医療分野:企業M&A・提携分析
    Summary CEL-SCI Corp (CEL-SCI) is a biotechnology company that carries out the research and development of new immunotherapy products for the treatment of various cancer and infectious diseases. Its core capabilities include drug discovery, research, development and manufacturing of compound biologi …
  • Heidelberger Druckmaschinen AG (HDD):企業の財務・戦略的SWOT分析
    Heidelberger Druckmaschinen AG (HDD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Mercury NZ:戦略・SWOT・企業財務分析
    Mercury NZ - Strategy, SWOT and Corporate Finance Report Summary Mercury NZ - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Egalet Corp (EGLT):医療機器:M&Aディール及び事業提携情報
    Summary Egalet Corp (Egalet) is a specialty pharmaceutical company that develops, manufactures and commercializes novel treatments for pain and other conditions. Its product portfolio includes OXAYDO (oxycodone HCl, USP) tablets CII for the management of acute and chronic moderate to severe pain; SP …
  • GlaxoSmithKline Plc (GSK):医療機器:M&Aディール及び事業提携情報
    Summary GlaxoSmithKline Plc (GSK) is a healthcare company, which focuses on the development, manufacture and commercialization of pharmaceuticals, vaccines and consumer healthcare products. It offers drugs for the treatment of HIV, respiratory, cancer, immuno-inflammation, anti-virals, central nervo …
  • The Sherwin-Williams Company:企業の戦略・SWOT・財務分析
    The Sherwin-Williams Company - Strategy, SWOT and Corporate Finance Report Summary The Sherwin-Williams Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Definiens AG:医療機器:M&Aディール及び事業提携情報
    Summary Definiens AG (Definiens), a subsidiary of AstraZeneca Plc, is a healthcare technology company that offers image analysis and data mining solutions. The company offers products such as tissue studio, developer, image miner, server, architect and viewer, among others. Its services include cons …
  • MDC Partners Inc.:企業のM&A・事業提携・投資動向
    MDC Partners Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's MDC Partners Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • McLane Company Inc:戦略・SWOT・企業財務分析
    McLane Company Inc - Strategy, SWOT and Corporate Finance Report Summary McLane Company Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • MannKind Corp (MNKD):製薬・医療:M&Aディール及び事業提携情報
    Summary MannKind Corp (MannKind) is a biopharmaceutical company that develops and commercializes inhaled therapeutic products for patients suffering from diabetes and pulmonary arterial hypertension. Its flagship product, Afrezza is a US FDA approved rapid-action inhaled insulin used to control high …
  • OneWorld Health-製薬・医療分野:企業M&A・提携分析
    Summary OneWorld Health (iOWH) is a healthcare service provider that discovers, develops, and delivers safe, effective, and affordable new treatments for diseases disproportionately affecting people in the world. The center treats infectious diseases such as diarrheal diseases, visceral leishmaniasi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆